CWM
IBB icon

Chemistry Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Chemistry Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$654K Hold
3,436
– – 0.1% 114
2026
Q1 		$580K Sell
3,436
-50
-1% -$8.55K 0.1% 110
2025
Q4 		$588K Hold
3,486
– – 0.11% 108
2025
Q3 		$503K Hold
3,486
– – 0.1% 119
2025
Q2 		$441K Sell
3,486
-127
-4% -$15.6K 0.09% 118
2025
Q1 		$462K Hold
3,613
– – 0.11% 108
2024
Q4 		$478K Hold
3,613
– – 0.11% 106
2024
Q3 		$526K Buy
3,613
+53
+1% +$7.67K 0.12% 101
2024
Q2 		$489K Hold
3,560
– – 0.13% 100
2024
Q1 		$488K Buy
3,560
+609
+21% +$83.2K 0.13% 101
2023
Q4 		$401K Buy
2,951
+1
+0% +$122 0.12% 106
2023
Q3 		$361K Hold
2,950
– – 0.12% 106
2023
Q2 		$375K Hold
2,950
– – 0.12% 111
2023
Q1 		$381K Buy
2,950
+52
+2% +$6.81K 0.13% 106
2022
Q4 		$381K Buy
2,898
+5
+0.2% +$646 0.15% 96
2022
Q3 		$338K Sell
2,893
-128
-4% -$15.9K 0.13% 104
2022
Q2 		$355K Buy
3,021
+203
+7% +$24.1K 0.14% 109
2022
Q1 		$367K Buy
+2,818
New +$367K 0.13% 109

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Chemistry Wealth Management's IBB Position: Q2 2026 in Review

Chemistry Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,436 shares worth $654K. The position accounts for 0.1% of the portfolio, ranked #114.

Chemistry Wealth Management first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. 222 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Chemistry Wealth Management held 3,436 shares of iShares Biotechnology ETF worth $654K as of Q2 2026.
  • Chemistry Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.1% of Chemistry Wealth Management's portfolio in Q2 2026, its #114 holding.
  • Chemistry Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
  • 222 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.